PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

SEEP Consensus on Pediatric Type 1 Diabetes in Special Situations

SEEP consensus recommendationsSpanish Society of Pediatric Endocrinologytype 1 diabetesinsulinglucagonAID systemsCSIICGM Pediatric Pharmacy

Background Information

New consensus guides T1D management in special situations for children and adolescents.

Managing type 1 diabetes (T1D) in children and adolescents during special situations is crucial to prevent complications and optimize health outcomes. This guideline offers consensus recommendations based on the latest protocols from the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the American Diabetes Association (ADA). The recommendations provide detailed guidance on treatment modalities to optimize glycemic control and manage acute complications in young patients with T1D. Updated consensus recommendations assist in managing young patients with T1D during special situations.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Gil Poch E, Ferrer Lozano M, Murillo Vallés M, Cardona-Hernandez R, Clemente León M, Itza Martín N, Leiva-Gea I, Pérez Sánchez J, Ros Pérez P, Bahillo Curieses MP

Citation: Gil Poch E, Ferrer Lozano M, Murillo Vallés M, et al. Clinical recommendations for the management of patients with type 1 diabetes in special situations. Anales de pediatria. 2026:504266. doi:10.1016/j.anpede.2026.504266

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →